Sonoma Pharmaceuticals Inc. (SNOA) Volatility At 12.37%, Should You Add A Position?

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) is -11.20% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SNOA stock was last observed hovering at around $0.16 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $0.16, the stock is -8.17% and -8.94% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing -2.32% at the moment leaves the stock -76.49% off its SMA200. SNOA registered -89.92% loss for a year compared to 6-month loss of -84.14%. The firm has a 50-day simple moving average (SMA 50) of $0.05 and a 200-day simple moving average (SMA200) of -$0.11.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a -12.93% gain in the last 1 month and extending the period to 3 months gives it a -4.53%, and is -7.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.37% over the week and 20.52% over the month.

Sonoma Pharmaceuticals Inc. (SNOA) has around 171 employees, a market worth around $2.19M and $12.12M in sales. Profit margin for the company is -50.75%. Distance from 52-week low is 38.22% and -89.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.85%).

Sonoma Pharmaceuticals Inc. quarterly earnings per share for the current quarter are estimated at -$0.21 with sales reaching $3.76M over the same period., but quarterly earnings will post 10.40% year-over-year. Quarterly sales are estimated to grow 27.70% in year-over-year returns.

13 institutions hold shares in Sonoma Pharmaceuticals Inc. (SNOA), with institutional investors hold 0.94% of the company’s shares. The shares outstanding are 13.68M, and float is at 13.46M with Short Float at 5.02%. Institutions hold 0.92% of the Float.

The top institutional shareholder in the company is Two Sigma Securities, LLC with over 52042.0 shares valued at $55684.0. The investor’s holdings represent 1.01% of the SNOA Shares outstanding. As of Jun 29, 2023, the second largest holder is Geode Capital Management, LLC with 36214.0 shares valued at $38748.0 to account for 0.70% of the shares outstanding. The other top investors are State Street Corporation which holds 24315.0 shares representing 0.47% and valued at over $26017.0, while Renaissance Technologies, LLC holds 0.43% of the shares totaling 22206.0 with a market value of $23760.0.

Sonoma Pharmaceuticals Inc. (SNOA) Insider Activity

A total of 0 insider transactions have happened at Sonoma Pharmaceuticals Inc. (SNOA) in the last six months, with sales accounting for 0 and purchases happening 0 times.